Main competitors
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
15
29
22
29
18
21
21
24
30
28
27
29
25
19
23
15
15
16
18
Average 22
Weighted average by Cap. 25
Other Pharmaceuticals